Cite

HARVARD Citation

    Gao, J. et al. (2021). Multiple genetic variants predict the progression-free survival of bevacizumab plus chemotherapy in advanced ovarian cancer. Medicine. 100 (35), p. . [Online]. 
  
Back to record